Mr. Hector Bremner reports

HEALTHTAB SIGNS RESELLER AGREEMENT WITH ABBOTT TO SUPPORT UK EXPANSION

Avricore Health Inc. has signed a reseller agreement between HealthTab Inc. and Abbott Rapid Dx UK & Ireland.

This agreement provides a foundation for HealthTab to purchase and distribute the Afinion 2 and associated tests for diabetes and heart disease screening in community pharmacies in the United Kingdom.

"As we've grown in Canada substantially in collaboration with Abbott, we're excited to take this winning model to the UK," said Hector Bremner, chief executive officer of Avricore Health. "We believe the U.K. is one of the leading jurisdictions to bring more funding for pharmacists to deliver services and that demand for HealthTab will be significant."

HealthTab is currently in over 530 pharmacies in Canada and is leading a move to greater sophistication in point-of-care testing in community pharmacies, bringing high-quality instruments, robust health data management and quality assurance.

United Kingdom health care demands need pharmacy

It is estimated that there are over five million people with undiagnosed hypertension in the United Kingdom today.

NHS (National Health Service) England recently announced 645 million British pounds to support increasing access to primary care, including expanding clinical practice in pharmacy, as an essential part of recovering the system's ability to deliver timely service.

It is estimated that optimally treating high-risk atrial fibrillation patients would prevent over 14,000 strokes over three years and save the NHS nearly 242 million British pounds.

The NHS notes that high cholesterol, along with other factors, is a major factor in heart attack and stroke risk; however, late diagnosis or undertreatment is very common.

There are over 13,000 pharmacies in the United Kingdom, serving a population of over 67 million people, of which, 96 per cent live within 20 minutes by walking or using transit of a community pharmacy.

About HealthTab

HealthTab is a turnkey point-of-care testing solution that combines best-in-class point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data are reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (for example, HbA1c, lipid profile and eGFR (estimated glomerular filtration rate)). HealthTab has also recently added capabilities for bacterial and viral tests, such as strep and COVID-19.

The HealthTab network model is unlike anything in pharmacy today. It gives knowledgeable and trusted pharmacists a greater role in primary care delivery while empowering patients to take more control of their health. It also reduces costs and waiting times and provides many potential revenue streams, including equipment leasing and consumables, direct access testing, disease prevention and management programs, sponsored health programs, decentralized clinical trials, real-world data (RWD) sets, and third party app integration through API (application programming interface).

HealthTab market fast facts:

• Point-of-care testing market to reach $50.6-billion (U.S.) in 2025;
• Glucose monitoring (diabetes related) to make up the largest growth within the sector;
• Nearly 13.6 million Canadians expected to diabetic or prediabetic by 2030, with many undiagnosed;
• Over one in three Americans, approximately 88 million people, have prediabetes;
• Close to 160,000 Canadians 20 years and older are diagnosed with heart disease each year; often it is only after a heart attack they are diagnosed;
• There are more than 10,000 pharmacies in Canada, 88,000 pharmacies in the United States and nearly 12,000 in the United Kingdom.

About Avricore Health Inc.

Avricore Health is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world's largest network of rapid testing devices in community pharmacies.

We seek Safe Harbor.